$Eli Lilly and Co (LLY.US)$ FDA Approves Lilly's EBGLYSS™ (l... - moomoo Community

Log Out

Rafey Jan commented on a stock · Sep 13 15:11

$Eli Lilly and Co (LLY.US)$

FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

32K Views

Comment

Sign in to post a comment

20Followers

58Following

110Visitors

Follow